Natco Pharma Ltd.

Natco Pharma is currently trading at Rs. 2300.20, up by 56.85 points or 2.53% from its previous closing of Rs. 2243.35 on the BSE.

The scrip opened at Rs. 2248.00 and has touched a high and low of Rs. 2315.20 and Rs. 2237.35 respectively. So far 2292 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 2709.00 on 07-Apr-2015 and a 52 week low of Rs. 1233.00 on 01-Sep-2014.

Last one week high and low of the scrip stood at Rs. 2337.45 and Rs. 2060.00 respectively. The current market cap of the company is Rs. 7455.74 crore.

The promoters holding in the company stood at 53.76% while Institutions and Non-Institutions held 15.02% and 31.23% respectively.

Natco Pharma is planning an aggressive capex in Andhra Pradesh, Telangana and Tamil Nadu. The company is setting up a formulations facility in the Pharma City in Visakhapatnam which will be ready by the end of next year. In addition, the company will be expanding research and development facility, chemical manufacturing facilities in Telangana and Tamil Nadu besides formulation facility in Hyderabad.

Recently, the company received approval from the Foreign Investment Promotion Board (FIPB) to raise up to Rs 450 crore by issuing securities to Qualified Institutional Buyers. It had also given nod to a proposal for increasing foreign investment limit from 24 percent to 31.5 percent of the paid up equity share capital of the company.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.